ClinicalTrials.gg
RecruitingNCT07028450Updated May 11, 2026

Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled Study

An interventional study of Proactive call in Gambling Problem, sponsored by University of Bergen. Recruiting at 1 site in Norway. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by University of Bergen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
195
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Customers/gamblers gambling at Norsk Rikstoto (gambling monopolist in Norway providing horse gambling products with potential gambling problems will be randomly allocated to receive a proactive phone call (encouraging them to change their gambling behavior - e.g., be lowering the loss limit) or to a control condition. Outcomes will be short and long terms registered gambling behavior.

Read the detailed description

Norsk Rikstoto (gambling monopolist in Norway providing horse gambling products) enforces registered play, hence all gambling transactions and outcomes of stakes of all customers are registered and stored for 5 years. Based on daily algorithms high risk gamblers are identified. Gamblers 18-50 years who for at least 5 of the last 30 days have been identified as high risk gamblers will according to a 1.5:1 ratio be allocated to a proactive call condition or to a control condition.

The call will be based on principles from motivating interviewing and will contain encouragements to alter gambling behavior (e.g., lowering loss limits). Primary outcome comprises theoretical loss (total bet x house advantage ((100% - payback%) / 100)). Secondary outcomes comprises total stakes made by the customer and loss percentage (proportion of stake that is lost). Baseline data comprises gambling behavior the 30 days before the call. Short-term effects comprise cumulative registered gambling behavior the first 90 days after the call whereas long-term effects consist of cumulative registered gambling behavior day 91-180 after the call. A random block design will be used where 15 eligible customers each week will be allocated either to the proactive call condition (n=9) or to the control condition (n=6).

02

Conditions studied

  • Gambling Problem

Browse trials for

Keywords

  • Gambling Problem
  • Proactive calls
  • Randomized controlled trial
  • mini-intervention
03

In context

Gambling

158 studies on the registry are indexed under Gambling; 42 are open to participants now.

This study's planned enrollment of 195 is above the median of 66 across 128 interventional studies indexed under Gambling.

Browse Gambling studies →

Lead sponsor

University of Bergen is the lead sponsor of 143 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being identified (based on an algorithm used by Norsk Rikstoto/the gambling provider) as a high risk gambler at least 5 of the last 30 days

Exclusion criteria

Exclusion Criteria:

  • Previously received a proactive call from Norsk Rikstoto
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
195 participants (estimated)

Study arms

  • Experimental
    One proactive call

    The call is based on principles of motivating interviewing and will in addition encourage the recipient to change his/hers gambling behavior (e.g., lower pre-set loss limits).

    Behavioral: Proactive call

  • No intervention
    Control

    No contact/not reaching out

Interventions

  • BehavioralProactive call

    The proactive call will be based on the principles of motivational interviewing. The content of the call comprises: 1) Asking the gambler/recipient to reflect on their gambling behavior, 2) providing to the gambler/recipient an overview of their gambling account and financial history, 3) offering to the gambler/recipient information about responsible gambling tools, such as setting lower limits, locking limits, taking a break, or self-exclusion, and 4) providing to the gambler/recipient information about relevant support services and the Gamban tool in cases where a need is expressed.

06

What researchers measure

Primary outcomes

  1. Theoretical loss

    Total bet x house advantage ((100%-payback%) / 100)

    Time frame: Change from baseline (30 days before the call) to day 1-90 after the call (short-term effect) and change from baseline (30 days before the call) to day 91-180 after the call (long-term effect).

Secondary outcomes

  1. Total stake

    Total amount of money staked

    Time frame: Change from baseline (30 days before the call) to the first 90 days after the call (short term) and change from baseline to day 91-180 after the call

  2. Loss percentage

    Percentage of stakes that are lost

    Time frame: Change from baseline (30 days before the call) to day 1-90 after the call (short-term effect) and change from baseline (30 days before the call) to day 91-180 after the call (long-term effect).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Researchers may contact the principle investigator and ask for access to the data in anonymous form

Supporting information: Study protocol, Statistical analysis plan

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.

Of 47 non-industry interventional studies with no phase under Gambling, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 10 months is below that.

Counting every sponsor, half of 47 studies reached it within 16 months; a quarter within 10 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2025
First posted
Jun 19, 2025
StartActual
Feb 16, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
May 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07028450
Responsible party
Sponsor
First posted
Jun 19, 2025
Start date
Feb 16, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 11, 2026

Study contacts

Ståle Pallesen, PhD
Contact
staale.pallesen@uib.no
+4792632099
Andre Syvertsen, PhD
Contact
andre.syvertsen@uib.no
+4795137908

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion